Clinical Therapeutics

About the journal

The International Peer-Reviewed Journal of Drug Therapy

Clinical Therapeutics provides peer-reviewed, rapid publication of recent developments in drug and other therapies as well as in diagnostics, pharmacoeconomics, health policy, treatment outcomes, and innovations in drug and biologics …

$4340

Article publishing charge
for open access

13 days

Time to first decision

82 days

Review time

98 days

Submission to acceptance

View all insights

Co Editors-in-Chief

View full editorial board

Jill L. Maron, MD, MPH

Women & Infants Hospital of Rhode Island, Providence, Rhode Island, United States of America

Paul Beninger, MD, MBA

Tufts University School of Medicine, Boston, Massachusetts, United States of America

Articles

EditorialNo access

Adapting and Advancing the Criteria for Scientific Evidence, Marketing, and Advice in the Changing World

Jill L. Maron

March 2024

Research articleOpen access

First Report of Inclisiran Utilization for Hypercholesterolemia Treatment in Real-world Clinical Settings in a Middle East Population

Sajid Iqbal, ... Adam Buckley

March 2024View PDF

Research articleOpen access

A Physiologically Based Pharmacokinetic Modeling Approach to Assess the Potential for Drug Interactions Between Trofinetide and CYP3A4-Metabolized Drugs

Mona Darwish, ... Heather Bradley

March 2024View PDF

Research articleAbstract only

Low-dose Naltrexone Improves post–COVID-19 condition Symptoms

Leonardo Tamariz, ... Ana Palacio

March 2024

Research articleOpen access

Predicting Factors of Long-term Outcome of Gastrointestinal Behçet's Disease: A Chinese Retrospective Study

Xiaoman Zu, ... Yao He

March 2024View PDF

Research articleOpen access

Real-world Data and Evidence to support a switch in status from Prescription drug to Over the Counter drug as applied by the EMA, the US FDA, the MHRA, and the BfArM

Thomas C. Kühler, ... Souha Mékary-Sawaya

March 2024View PDF

Research articleOpen access

Advanced Model-based Approach to Evaluate Human Plasma, Cerebrospinal Fluid, and Neuronal mTORC1 Activation Biomarkers After NV-5138 Administration in Healthy Volunteers

Azmi Nasser, ... Thomas E. Hughes

March 2024View PDF

Research articleOpen access

A Relative Bioavailability, Bioequivalence, and Food Effect Study of Niraparib Tablets in Patients with Advanced Solid Tumors

Gerald Falchook, ... Elizabeth Potocka

March 2024View PDF

Read latest issue

Calls for papers

Extraglycemic Effects of SGLT2 Inhibitors and GLP-1-Based Therapies

Guest editor: Dr. Uazman Alam Submission deadline: 30 April 2024

This specialty update focuses on extraglycemic effects of SGLT2 inhibitors and GLP-1-based therapies, and seeks to comprehensively explore these multifaceted impacts and illuminate their clinical significance.

Submission deadline: 30 April 2024

Advancements and Innovative Strategies in Pediatric Drug Development

Guest editor: Dr. Yuli Qian - Submission deadline: 30 April 2024

The objective of this specialty update is to review recent advancements in pediatric drug development and novel strategies utilized to accelerate pediatric drug development and achieve more informed dose selection.

Submission deadline: 30 April 2024

View all calls for papers for special issues

View all special issues and article collections

View all issues

Print ISSN: 0149-2918

Online ISSN: 1879-114X

Clinical Therapeutics

About the journal

Aims & Scope

Co Editors-in-Chief

Jill L. Maron, MD, MPH

Paul Beninger, MD, MBA

Articles

Latest published

Articles in press

Top cited

Most downloaded

Most popular

Adapting and Advancing the Criteria for Scientific Evidence, Marketing, and Advice in the Changing World

First Report of Inclisiran Utilization for Hypercholesterolemia Treatment in Real-world Clinical Settings in a Middle East Population

A Physiologically Based Pharmacokinetic Modeling Approach to Assess the Potential for Drug Interactions Between Trofinetide and CYP3A4-Metabolized Drugs

Low-dose Naltrexone Improves post–COVID-19 condition Symptoms

Predicting Factors of Long-term Outcome of Gastrointestinal Behçet's Disease: A Chinese Retrospective Study

Real-world Data and Evidence to support a switch in status from Prescription drug to Over the Counter drug as applied by the EMA, the US FDA, the MHRA, and the BfArM

Advanced Model-based Approach to Evaluate Human Plasma, Cerebrospinal Fluid, and Neuronal mTORC1 Activation Biomarkers After NV-5138 Administration in Healthy Volunteers

A Relative Bioavailability, Bioequivalence, and Food Effect Study of Niraparib Tablets in Patients with Advanced Solid Tumors

More from Clinical Therapeutics

News

Announcements

Call for papers

Clinical Therapeutics: A Fresh Look and Enhanced Reading Experience

Calls for papers

Extraglycemic Effects of SGLT2 Inhibitors and GLP-1-Based Therapies

Advancements and Innovative Strategies in Pediatric Drug Development

Special issues and article collections

Gastroenterology Update: Alcohol Use Disorder

Cardiology and Cardiovascular Diseases Update: Atherosclerotic Cardiovascular Disease

Geriatric Therapeutics Update: Deprescribing in Older Adults

Rheumatology Update: Advances in Psoriatic Arthritis